ClinicalTrials.Veeva

Menu

OCT Angiography in Vitreo and Chorioretinal Pathologies

C

CRG UZ Brussel

Status

Unknown

Conditions

Optical Coherence Tomography

Treatments

Diagnostic Test: Optical coherence tomography angiography under dark and light adaptation

Study type

Observational

Funder types

Other

Identifiers

NCT03390205
2812201748151

Details and patient eligibility

About

In many diseases of the vitreo and chorioretinal complex, perfusion changes have a diagnostic, prognostic or causative role. The visualisation of perfusion was limited to invasive techniques, which were only to depict vasculature in one plane. Optical coherence tomography is able to visualise and quantify eye perfusion layer-specific and non-invasive.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient with vitreo and chorioretinal pathology, aged-adapted controls

Exclusion criteria

  • Minors, concomitant ocular pathologies, pregnancy, contra-indication for tropicamide

Trial design

100 participants in 2 patient groups

Patients
Treatment:
Diagnostic Test: Optical coherence tomography angiography under dark and light adaptation
Controls
Treatment:
Diagnostic Test: Optical coherence tomography angiography under dark and light adaptation

Trial contacts and locations

0

Loading...

Central trial contact

Pieter Jan Nelis, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems